Personal information

Websites & social links

ResearchGate
Google Scholar

Other IDs

Loop profile: 2036421

Activities

Collapse all

Employment (2)

Universitätsklinikum Mannheim Klinik für Dermatologie Venerologie und Allergologie: Mannheim, Baden-Württemberg, DE

Employment
Source: Self-asserted source
Feyza Gul Ozbay Kurt

German Cancer Research Center: Heidelberg, DE

PhD (Skin Cancer Unit)
Employment
Source: Self-asserted source
Feyza Gul Ozbay Kurt

Works (13)

S100A9 and HMGB1 orchestrate MDSC-mediated immunosuppression in melanoma through TLR4 signaling

Journal for ImmunoTherapy of Cancer
2024-08 | Journal article
DOI: 10.1136/jitc-2024-009552
Contributors: Feyza Gül Özbay Kurt; Beatrice-Ana Cicortas; Bianca M Balzasch; Carolina De la Torre; Volker Ast; Ece Tavukcuoglu; Cagla Ak; Sebastian A Wohlfeil; Adelheid Cerwenka; Jochen Utikal et al.
Source: check_circle
Crossref

Generation of Myeloid-Derived Suppressor Cells Mediated by MicroRNA-125a-5p in Melanoma

International Journal of Molecular Sciences
2024-06 | Journal article | Author
DOI: 10.3390/ijms25126693
Contributors: Samantha Lasser; Feyza Gul Ozbay Kurt; Lennart Fritz; Nina Gutzeit; Carolina De La Torre; Peter Altevogt; Jochen Utikal; Viktor Umansky
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Myeloid-derived suppressor cells in cancer and cancer therapy

Nature Reviews Clinical Oncology
2024-02 | Journal article
DOI: 10.1038/s41571-023-00846-y
Contributors: Samantha A. Lasser; Feyza G. Ozbay Kurt; Ihor Arkhypov; Jochen Utikal; Viktor Umansky
Source: check_circle
Crossref

Melanoma patients with immune-related adverse events after immune checkpoint inhibitors are characterized by a distinct immunological phenotype of circulating T cells and M-MDSCs

OncoImmunology
2023-12-31 | Journal article
DOI: 10.1080/2162402x.2023.2247303
Part of ISSN: 2162-402X
Contributors: Alisa Lepper; Rebekka Bitsch; Feyza Gül Özbay Kurt; Ihor Arkhypov; Samantha Lasser; Jochen Utikal; Viktor Umansky
Source: Self-asserted source
Feyza Gul Ozbay Kurt

Enhancing immunotherapy response in melanoma: myeloid-derived suppressor cells as a therapeutic target

Journal of Clinical Investigation
2023-07-03 | Journal article
DOI: 10.1172/jci170762
Part of ISSN: 1558-8238
Contributors: Feyza Gul Ozbay Kurt; Samantha Lasser; Ihor Arkhypov; Jochen Utikal; Viktor
Source: Self-asserted source
Feyza Gul Ozbay Kurt

Booster dose of mRNA vaccine augments waning T cell and antibody responses against SARS-CoV-2.

Frontiers in immunology
2022-10-12 | Journal article
DOI: 10.3389/fimmu.2022.1012526
PMID: 36311732
PMC: PMC9597683
Contributors: Özbay Kurt FG; Lepper A; Gerhards C; Roemer M; Lasser S; Arkhypov I; Bitsch R; Bugert P; Altevogt P; Gouttefangeas C et al.
Source: Self-asserted source
Feyza Gul Ozbay Kurt

HSP90α induces immunosuppressive myeloid cells in melanoma via TLR4 signaling.

Journal for immunotherapy of cancer
2022-09-01 | Journal article
DOI: 10.1136/jitc-2022-005551
PMID: 36113897
PMC: PMC9486388
Contributors: Arkhypov I; Özbay Kurt FG; Rebekka Bitsch; Novak D; Petrova V; Lasser S; Hielscher T; Groth C; Lepper A; Hu X et al.
Source: Self-asserted source
Feyza Gul Ozbay Kurt

STAT3 inhibitor Napabucasin abrogates MDSC immunosuppressive capacity and prolongs survival of melanoma-bearing mice.

Journal for immunotherapy of cancer
2022-03-01 | Journal article
DOI: 10.1136/jitc-2021-004384
PMID: 35301236
PMC: PMC8932276
Contributors: Rebekka Bitsch; Kurzay A; Özbay Kurt F; De La Torre C; Lasser S; Lepper A; Siebenmorgen A; Müller V; Altevogt P; Utikal J et al.
Source: Self-asserted source
Feyza Gul Ozbay Kurt

Tumor promoting capacity of polymorphonuclear myeloid-derived suppressor cells and their neutralization.

International journal of cancer
2021-07-17 | Journal article
DOI: 10.1002/ijc.33731
PMID: 34224592
Contributors: Christopher Groth; Weber R; Lasser S; Özbay FG; Kurzay A; Petrova V; Altevogt P; Jochen Utikal; Viktor Umansky
Source: Self-asserted source
Feyza Gul Ozbay Kurt

Small cell lung cancer stem cells display mesenchymal properties and exploit immune checkpoint pathways in activated cytotoxic T lymphocytes.

Cancer immunology, immunotherapy : CII
2021-07-06 | Journal article
DOI: 10.1007/s00262-021-02998-1
PMID: 34228218
PMC: PMC8783896
Contributors: M. Alper Kursunel; Taskiran EZ; Ece Tavukcuoglu; Yanik H; Demirag F; Beren Karaosmanoglu; Ozbay FG; Uner A; Esendagli D; Kizilgoz D et al.
Source: Self-asserted source
Feyza Gul Ozbay Kurt

An immunological and transcriptomics approach on differential modulation of NK cells in multiple sclerosis patients under interferon-β1 and fingolimod therapy.

Journal of neuroimmunology
2020-07-30 | Journal article
DOI: 10.1016/j.jneuroim.2020.577353
PMID: 32745802
Contributors: Acar NP; Tuncer A; Ozkazanc D; Ozbay FG; Beren Karaosmanoglu; Goksen S; Sayat G; Taskiran EZ; Esendagli G; Karabudak R et al.
Source: Self-asserted source
Feyza Gul Ozbay Kurt

Development and in vitro evaluation of temozolomide-loaded PLGA nanoparticles in a thermoreversible hydrogel system for local administration in glioblastoma multiforme

Journal of Drug Delivery Science and Technology
2020-06 | Journal article
DOI: 10.1016/j.jddst.2020.101627
Part of ISSN: 1773-2247
Contributors: Ozgun Sayiner; Sema Arisoy; Tansel Comoglu; Feyza Gul Ozbay; Gunes Esendagli
Source: Self-asserted source
Feyza Gul Ozbay Kurt

Identification of circulating MOG-specific B cells in patients with MOG antibodies.

Neurology(R) neuroimmunology & neuroinflammation
2019-10-14 | Journal article
DOI: 10.1212/nxi.0000000000000625
PMID: 31611268
PMC: PMC6857907
Contributors: Stephan Winklmeier; Schlüter M; Spadaro M; Thaler FS; Atay Vural; Ramona Gerhards; Caterina Macrini; Mader S; Kurne A; Berin Inan et al.
Source: Self-asserted source
Feyza Gul Ozbay Kurt
How many people are using ORCID?